For research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
General control nonderepressible 2 (GCN2) is a serine/threonine-protein kinase that plays a key role in modulating amino acid metabolism as a response to nutrient deprivation. GCN2 is one of the four known sensors of the integrated stress response (ISR), which is a cytoprotective response mediated by eIF2α. Under conditions of amino acid deprivation, GCN2 inactivates eIF2α by phosphorylation, and eIF2α phosphorylation can also lead to enhanced transcription of mRNA molecules involved in host response to infection and inflammation. GCN2 is associated with cancer.
The AlphaLISA SureFire UltraHuman Phospho-GCN2 (Thr899) assay is a sandwich immunoassay for the quantitative detection of phospho-GCN2 (Thr899) in cellular lysates, using Alpha Technology.
| Assay Target | GCN2 |
|---|---|
| Assay Technology | Alpha |
| Automation Compatible | Yes |
| Detection Method | Alpha |
| Experimental Type | In vitro |
| Product Brand Name | AlphaLISA SureFire Ultra |
| Shipping Condition | Blue Ice |
| Target Species | Human |
| Therapeutic Area | Oncology |
| Unit Size | 10,000 Assay Points |
The introduction of enzyme-linked immunosorbent assays (ELISAs) in the early 1970’s offered researchers a non-radiometric immunoassay platform without compromising sensitivity. Over the last 50 years scientists have made huge strides in disease research and drug discovery and a demand for greater assay throughput and sensitivity has evolved. In response, more robust immunoassays have been developed to address some of the limitations of the standard, colorimetric ELISA.
Find out about the most common limitations of traditional ELISAs and how different ELISA alternative technologies address these limitations.
Product brochure for the Alpha Technology, a versatile, no wash, homogeneous assay technology that's suitable for a broad range of applications.
Find out about our range of integrated solutions for drug discovery screening in this e-brochure.
Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automated liquid handling, assays and reagents, imaging and detection systems, and informatics.
Working independently or together, with our solutions you can achieve consistent and accurate results. By accelerating the identification and characterization of effective and safe drug candidates, the PerkinElmer portfolio enables you to optimize efficiency in your lab and deliver more actionable, real-world results.
Download the brochure to learn more about how we can partner with you so that you can discover smarter, more effective, data-driven breakthroughs in the critical screening stages of drug discovery and development.
OptiPlate-384, White Opaque 384-well Microplate, Case 50
List Price : USD307.0
AlphaPlate-384, Light gray, untreated, Case of 50
List Price : USD567.0
List Price : USD70.0
